H.C. Wainwright Reiterates Buy Rating on Assembly Biosciences (ASMB)

August 18, 2026 6:41 AM

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $50.00 price target on Assembly Biosciences (NASDAQ: ASMB).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found